Caplin Group of Companies is pleased to announce the signing of a Memorandum of Understanding (MoU) with the Tamil Nadu Government during the Tamil Nadu Global Investors Meet, 2024 to invest Rs. 700 crores over a period of 5 years in diverse projects.

This investment will be made by Caplin Point Laboratories Limited and its subsidiaries - Caplin Steriles Limited and Caplin One Labs Limited.

The MoU specifies that the government will provide necessary infrastructure and regulatory assistance as per applicable laws. This will also enable the availing of standard incentives, subject to eligibility. The investments, spanning Oncology, Active Pharmaceutical Ingredients and R&D facilities, are projected to generate 1,500 employment opportunities (1,000 direct and 500 indirect).

Commenting on the achievement, C. C. Paarthipan, Chairman said, “We are pleased to announce the signing of an MoU with the Government of Tamil Nadu. Aligned with the state's goals, our company's strategic investment emphasizes expanding manufacturing capabilities and driving research and development. This proactive approach not only empowers economic growth but also highlights our strong commitment to positive societal impact and social development. We appreciate the government's crucial role in ensuring the success of these key projects.”

Caplin Point Laboratories Limited is a fast-growing pharmaceutical company with a unique business model catering predominantly to emerging markets of Latin America and Africa. The company has state of the art manufacturing facilities that cater to a complete range of finished dosage forms. Caplin Point is one of the few companies to show consistent high-quality growth in cash flows, Profitability and Revenues over the last 15 years.